Advancing core workflows with the Intabio ZT system
Advancing core workflows with the Intabio ZT system
Advancing core workflows with the Intabio ZT system
This event is now available on demand
Event Overview:
Characterization of charge isoforms, whether in early product development or associated with licensure filings, is usually achieved through separate analytical techniques. Fraction collection via ion-exchange (IEX) liquid chromatography or iCE followed by mass spectrometry are typically used.
This webinar discusses opportunities to advance core platform technologies through a fully integrated icIEF-UV/MS workflow on the Intabio ZT system and how rapid post-translational modification (PTM) characterization of charge isoforms can be used to guide decisions during early development.
Key Learning Objectives:
• Identify sequence variants with icIEF-UV/MS
• Identify charge variants of AAVs with icIEF-UV/MS
• Incorporate icIEF-UV/MS into existing standard operating procedures
• Understand the impact rapid charge variant identification has on drug development
Who Should Attend:
• Analytical development scientists
• Process development scientists
• Cell line development scientists
• Protein characterization scientists
Featured Speaker
Kristen Nields, PhD
Principal Scientist
Johnson & Johnson Innovative Medicine
Xiaoping He, PhD
Principal Scientist
Pfizer
For any technical questions please contact David Ambrose: Dambrose@mjhlifesciences.com